These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17477007)

  • 1. Most common breast cancer drops a dramatic 15%.
    McBride D
    ONS Connect; 2007 Apr; 22(4):22. PubMed ID: 17477007
    [No Abstract]   [Full Text] [Related]  

  • 2. Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?
    Soerjomataram I; Coebergh JW; Louwman MW; Visser O; van Leeuwen FE
    J Clin Oncol; 2007 Nov; 25(31):5038-9; author reply 5039-40. PubMed ID: 17971608
    [No Abstract]   [Full Text] [Related]  

  • 3. [The storm around hormonal replacement therapy].
    Heikinheimo O; Kaaja R
    Duodecim; 2002; 118(18):1833-5. PubMed ID: 12422665
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cancer decline mirrors fall in hormone use, spurs both debate and research.
    McNeil C
    J Natl Cancer Inst; 2007 Feb; 99(4):266-7. PubMed ID: 17312300
    [No Abstract]   [Full Text] [Related]  

  • 5. The Million Women Study and breast cancer.
    Speroff L
    Maturitas; 2003 Sep; 46(1):1-6. PubMed ID: 12963165
    [No Abstract]   [Full Text] [Related]  

  • 6. Study outlines further risks associated with hormone replacement therapy.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Sep; 14(17):1-2, 5. PubMed ID: 13677336
    [No Abstract]   [Full Text] [Related]  

  • 7. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone therapy and breast cancer risk: trumping fear with facts.
    Kaunitz AM
    Menopause; 2006; 13(2):160-3. PubMed ID: 16645526
    [No Abstract]   [Full Text] [Related]  

  • 9. The Million Women Study--is it believable?
    Farmer R
    Climacteric; 2005 Sep; 8(3):210-3. PubMed ID: 16390752
    [No Abstract]   [Full Text] [Related]  

  • 10. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 11. More controversy over breast cancer rates in the USA.
    Brown S
    Menopause Int; 2007 Jun; 13(2):51-2. PubMed ID: 17802647
    [No Abstract]   [Full Text] [Related]  

  • 12. Declining breast cancer incidence and decreased HRT use.
    Kumle M
    Lancet; 2008 Aug; 372(9639):608-10. PubMed ID: 18722851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Does menopausal hormonal replacement therapy increase the risk of breast cancer?].
    Punnonen R
    Duodecim; 1996; 112(12):1110-5. PubMed ID: 10593013
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone replacement therapy and risk of breast cancer.
    Grant EC
    JAMA; 2002 May; 287(18):2360; author reply 2361. PubMed ID: 11988049
    [No Abstract]   [Full Text] [Related]  

  • 15. Press statement. Breast cancer and hormone therapy: a looking-glass mirror?
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2007 Oct; 10(5):356-7. PubMed ID: 17852137
    [No Abstract]   [Full Text] [Related]  

  • 16. Declining breast cancer incidence and decreased HRT use.
    Brewster DH; Sharpe KH; Clark DI; Collins J
    Lancet; 2009 Feb; 373(9662):459-60; author reply 461. PubMed ID: 19200912
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estrogen replacement therapy and breast cancer].
    Zahl PH; Maehlen J
    Tidsskr Nor Laegeforen; 2005 Apr; 125(8):1045; author reply 1045. PubMed ID: 15852091
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.
    Clarke CA; Glaser SL; Uratsu CS; Selby JV; Kushi LH; Herrinton LJ
    J Clin Oncol; 2006 Nov; 24(33):e49-50. PubMed ID: 17114650
    [No Abstract]   [Full Text] [Related]  

  • 19. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative versus attributable risk of breast cancer from estrogen replacement therapy.
    Santen RJ; Petroni GR
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1875-81. PubMed ID: 10372679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.